原发性和假体关节感染相关翻修关节置换术后DAIR(清创、抗生素和植入物保留)手术一年感染控制率的回顾性队列研究

IF 1.8 Q3 INFECTIOUS DISEASES
Journal of Bone and Joint Infection Pub Date : 2021-01-27 eCollection Date: 2021-01-01 DOI:10.5194/jbji-6-91-2021
F Ruben H A Nurmohamed, Bruce van Dijk, Ewout S Veltman, Marrit Hoekstra, Rob J Rentenaar, Harrie H Weinans, H Charles Vogely, Bart C H van der Wal
{"title":"原发性和假体关节感染相关翻修关节置换术后DAIR(清创、抗生素和植入物保留)手术一年感染控制率的回顾性队列研究","authors":"F Ruben H A Nurmohamed,&nbsp;Bruce van Dijk,&nbsp;Ewout S Veltman,&nbsp;Marrit Hoekstra,&nbsp;Rob J Rentenaar,&nbsp;Harrie H Weinans,&nbsp;H Charles Vogely,&nbsp;Bart C H van der Wal","doi":"10.5194/jbji-6-91-2021","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>: Debridement, antibiotics and implant retention (DAIR) procedures are effective treatments for acute postoperative or acute hematogenous periprosthetic joint infections. However, literature reporting on the effectiveness of DAIR procedures performed after a one- or two-stage revision because of a prosthetic joint infection (PJI) (PJI-related revision arthroplasty) is scarce. The aim of this study is to retrospectively evaluate the infection control after 1 year of a DAIR procedure in the case of an early postoperative infection either after primary arthroplasty or after PJI-related revision arthroplasty. <b>Materials and methods</b>: All patients treated with a DAIR procedure within 3 months after onset of PJI between 2009 and 2017 were retrospectively included. Data were collected on patient and infection characteristics. All infections were confirmed by applying the Musculoskeletal Infection Society (MSIS) 2014 criteria. The primary outcome was successful control of infection at 1 year after a DAIR procedure, which was defined as the absence of clinical signs, such as pain, swelling, and erythema; radiological signs, such as protheses loosening; or laboratory signs, such as C-reactive protein (CRP) ( <math><mrow><mo><</mo> <mn>10</mn></mrow> </math> ) with no use of antibiotic therapy. <b>Results</b>: Sixty-seven patients were treated with a DAIR procedure (41 hips and 26 knees). Successful infection control rates of a DAIR procedure after primary arthroplasty ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>51</mn></mrow> </math> ) and after prior PJI-related revision arthroplasty ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>16</mn></mrow> </math> ) were 69 % and 56 %, respectively ( <math><mrow><mi>p</mi> <mo>=</mo> <mn>0.38</mn></mrow> </math> ). The successful infection control rates of a DAIR procedure after an early acute infection ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>35</mn></mrow> </math> ) and after a hematogenous infection ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>16</mn></mrow> </math> ) following primary arthroplasty were both 69 % ( <math><mrow><mi>p</mi> <mo>=</mo> <mn>1.00</mn></mrow> </math> ). <b>Conclusion</b>: In this limited study population, no statistically significant difference is found in infection control after 1 year between DAIR procedures after primary arthroplasty and PJI-related revision arthroplasty.</p>","PeriodicalId":15271,"journal":{"name":"Journal of Bone and Joint Infection","volume":"6 4","pages":"91-97"},"PeriodicalIF":1.8000,"publicationDate":"2021-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129908/pdf/","citationCount":"5","resultStr":"{\"title\":\"One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty - a retrospective cohort study.\",\"authors\":\"F Ruben H A Nurmohamed,&nbsp;Bruce van Dijk,&nbsp;Ewout S Veltman,&nbsp;Marrit Hoekstra,&nbsp;Rob J Rentenaar,&nbsp;Harrie H Weinans,&nbsp;H Charles Vogely,&nbsp;Bart C H van der Wal\",\"doi\":\"10.5194/jbji-6-91-2021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction</b>: Debridement, antibiotics and implant retention (DAIR) procedures are effective treatments for acute postoperative or acute hematogenous periprosthetic joint infections. However, literature reporting on the effectiveness of DAIR procedures performed after a one- or two-stage revision because of a prosthetic joint infection (PJI) (PJI-related revision arthroplasty) is scarce. The aim of this study is to retrospectively evaluate the infection control after 1 year of a DAIR procedure in the case of an early postoperative infection either after primary arthroplasty or after PJI-related revision arthroplasty. <b>Materials and methods</b>: All patients treated with a DAIR procedure within 3 months after onset of PJI between 2009 and 2017 were retrospectively included. Data were collected on patient and infection characteristics. All infections were confirmed by applying the Musculoskeletal Infection Society (MSIS) 2014 criteria. The primary outcome was successful control of infection at 1 year after a DAIR procedure, which was defined as the absence of clinical signs, such as pain, swelling, and erythema; radiological signs, such as protheses loosening; or laboratory signs, such as C-reactive protein (CRP) ( <math><mrow><mo><</mo> <mn>10</mn></mrow> </math> ) with no use of antibiotic therapy. <b>Results</b>: Sixty-seven patients were treated with a DAIR procedure (41 hips and 26 knees). Successful infection control rates of a DAIR procedure after primary arthroplasty ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>51</mn></mrow> </math> ) and after prior PJI-related revision arthroplasty ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>16</mn></mrow> </math> ) were 69 % and 56 %, respectively ( <math><mrow><mi>p</mi> <mo>=</mo> <mn>0.38</mn></mrow> </math> ). The successful infection control rates of a DAIR procedure after an early acute infection ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>35</mn></mrow> </math> ) and after a hematogenous infection ( <math><mrow><mi>n</mi> <mo>=</mo> <mn>16</mn></mrow> </math> ) following primary arthroplasty were both 69 % ( <math><mrow><mi>p</mi> <mo>=</mo> <mn>1.00</mn></mrow> </math> ). <b>Conclusion</b>: In this limited study population, no statistically significant difference is found in infection control after 1 year between DAIR procedures after primary arthroplasty and PJI-related revision arthroplasty.</p>\",\"PeriodicalId\":15271,\"journal\":{\"name\":\"Journal of Bone and Joint Infection\",\"volume\":\"6 4\",\"pages\":\"91-97\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2021-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129908/pdf/\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Bone and Joint Infection\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5194/jbji-6-91-2021\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bone and Joint Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5194/jbji-6-91-2021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 5

摘要

简介:清创,抗生素和种植体保留(DAIR)程序是有效的治疗急性术后或急性血行性假体周围关节感染。然而,由于假体关节感染(PJI) (PJI相关翻修关节置换术)而进行一期或两期翻修后DAIR手术的有效性的文献报道很少。本研究的目的是回顾性评估原发性关节置换术或pji相关翻修关节置换术后早期感染的DAIR手术后1年的感染控制情况。材料和方法:回顾性纳入2009年至2017年PJI发病后3个月内接受DAIR手术治疗的所有患者。收集患者和感染特征的数据。所有感染均采用肌肉骨骼感染学会(MSIS) 2014年标准确诊。主要结局是在DAIR手术后1年成功控制感染,其定义为没有临床症状,如疼痛、肿胀和红斑;放射学征象,如假体松动;或实验室体征,如c反应蛋白(CRP)(10),不使用抗生素治疗。结果:67例患者接受了DAIR手术(41髋和26膝)。初次关节置换术(n = 51)和先前pji相关翻修关节置换术(n = 16)后DAIR手术成功感染控制率分别为69 %和56 % (p = 0.38)。早期急性感染(n = 35)和原发性关节置换术后血液感染(n = 16)后DAIR手术的成功感染控制率均为69 % (p = 1.00)。结论:在这个有限的研究人群中,原发性关节置换术后DAIR手术和pji相关翻修关节置换术后1年感染控制没有统计学上的显著差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty - a retrospective cohort study.

One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty - a retrospective cohort study.

One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty - a retrospective cohort study.

Introduction: Debridement, antibiotics and implant retention (DAIR) procedures are effective treatments for acute postoperative or acute hematogenous periprosthetic joint infections. However, literature reporting on the effectiveness of DAIR procedures performed after a one- or two-stage revision because of a prosthetic joint infection (PJI) (PJI-related revision arthroplasty) is scarce. The aim of this study is to retrospectively evaluate the infection control after 1 year of a DAIR procedure in the case of an early postoperative infection either after primary arthroplasty or after PJI-related revision arthroplasty. Materials and methods: All patients treated with a DAIR procedure within 3 months after onset of PJI between 2009 and 2017 were retrospectively included. Data were collected on patient and infection characteristics. All infections were confirmed by applying the Musculoskeletal Infection Society (MSIS) 2014 criteria. The primary outcome was successful control of infection at 1 year after a DAIR procedure, which was defined as the absence of clinical signs, such as pain, swelling, and erythema; radiological signs, such as protheses loosening; or laboratory signs, such as C-reactive protein (CRP) ( < 10 ) with no use of antibiotic therapy. Results: Sixty-seven patients were treated with a DAIR procedure (41 hips and 26 knees). Successful infection control rates of a DAIR procedure after primary arthroplasty ( n = 51 ) and after prior PJI-related revision arthroplasty ( n = 16 ) were 69 % and 56 %, respectively ( p = 0.38 ). The successful infection control rates of a DAIR procedure after an early acute infection ( n = 35 ) and after a hematogenous infection ( n = 16 ) following primary arthroplasty were both 69 % ( p = 1.00 ). Conclusion: In this limited study population, no statistically significant difference is found in infection control after 1 year between DAIR procedures after primary arthroplasty and PJI-related revision arthroplasty.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
29
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信